China has taken a series of actions in the past week on counter-narcotics, in a sign of cooperation with U.S. demands for ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, ...

Historic changes are afoot for pharma as China gains ground on U.S. production. The pharma industry is projected to see ...

President Trump has threatened to impose pharma tariffs to encourage investment in U.S. manufacturing, but experts say there could be unintended consequences.

Hopefully the pro-trade members of California’s congressional delegation, especially its Republicans who have strong ties ...

In May, Pfizer spent $1.25 billion upfront for the right to license an experimental cancer drug from China's 3SBio. That is ...

Supply-chain decoupling doesn’t stop rival nations from hacking each other and can make it worse. A cyber-espionage expert ...

Here are the key issues at play: India's dependence on agriculture - a major source of rural jobs - has made it politically ...

Healthcare leaders are navigating the new era of trade policy following a series of tariffs recently imposed by President Donald Trump. Here are six takeaways on where tariffs stand now: ...

Fortunately, nothing is compelling President Trump to levy tariffs on medicines from allies. There’s no national security ...

A keenly-eyed India-US interim trade arrangement hangs in balance due to tariff disputes on steel, auto parts, and ...

The remarks suggest that Brussels could – like the UK – accept a 10% levy on most European exports in order to avoid ...